Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Circumvent Pharmaceuticals

Circumvent Pharmaceuticals
PRIVATE STATUS
Grant LATEST DEAL TYPE
$199K LATEST DEAL AMOUNT
4 INVESTORS
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 4640 South West Macadam Avenue
  • Suite 200
  • Portland, OR 97239
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Circumvent Pharmaceuticals’s full profile, request a free trial.

Circumvent Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 01-Jan-2017 $199K Completed Startup
2. Accelerator/Incubator Completed Startup
1. Seed Round Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Circumvent Pharmaceuticals Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
Center for Advancing Innovation Other 000 0000 000000 0
Heritage Provider Network Corporation Minority 000 0000 000000 0
OTRADI Bioscience Incubator Accelerator/Incubator Minority 000 0000 000000 0

Circumvent Pharmaceuticals Executive Team (1)

Name Title Board
Seat
Contact
Info
Andrew Lim Chief Executive Officer